International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 5 of the 68 sources its claims cite were checked for support.
Abstract
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort. The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some …
Overview
CoChat Summary
## TL;DR
This IADPSG consensus report recommends new gestational diabetes mellitus (GDM) diagnostic thresholds based on HAPO study data, using a 75-g OGTT and outcome-linked glucose cutoffs. It also recommends early detection of overt diabetes in pregnancy and notes that these recommendations will increase the frequency of diagnosed hyperglycemic disorders in pregnancy.
## Key findings
- In the HAPO study, a 75-g OGTT was performed in a heterogeneous, multinational, multicultural, ethnically diverse cohort of approximately 25,000 women in the third trimester; medical caregivers were blinded unless predefined glucose criteria were exceeded.
- The report states that the HAPO data showed continuous, graded associations between maternal glucose and primary outcomes, with no obvious thresholds; associations were also observed for secondary outcomes and did not differ among centers.
- The recommended diagnostic thresholds correspond to glucose levels where odds for birth weight >90th percentile, cord C-peptide >90th percentile, and percent body fat >90th percentile reached 1.75 times the estimated odds at mean glucose values; by these criteria, FPG alone identified 8.3% of the HAPO cohort, FPG plus 1-hour glucose identified an additional 5.7%, and 2-hour glucose another 2.1%, for a total GDM incidence of 17.8%.
- Among the HAPO cohort, 11.1% had only one elevated result, 3.9% had two elevated results, 1.1% had all three elevated, and 1.7% were unblinded because FPG or 2-hour glucose exceeded 5.8 mmol/l (105 mg/dl) or 11.1 mmol/l (200 mg/dl).
## Methods
- Consensus report based on review of the HAPO study, additional unpublished HAPO findings, and other published studies discussed at a June 2008 IADPSG workshop/meeting in Pasadena, followed by consensus panel deliberation.
- HAPO design described as observational: a 75-g OGTT in a large multinational cohort, with blinded caregivers except for preset safety thresholds.
- Thresholds were derived from fully adjusted logistic regression models relating continuous maternal glucose measures (FPG, 1-hour, 2-hour) to outcomes; the panel selected an odds ratio threshold of 1.75 relative to mean glucose values.
## Limitations
- The paper states that recommendations for detecting overt diabetes during pregnancy are based on the opinions of the IADPSG Consensus Panel because prospective studies or appropriately designed clinical trials were not available.
- It states that it was not determined whether universal early testing for overt diabetes is clinically valuable or cost-effective.
- Evident from the text: the HAPO study was observational, not a clinical trial, so the diagnostic thresholds are inferred from associations rather than randomized intervention effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 36 Not checked · 22 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Similar associations were also observed for secondary outcomes (25,26).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
The Abstract of our copy states that the predefined primary outcomes (size at birth, cesarean delivery, neonatal hypoglycemia, fetal hyperinsulinemia) were reported elsewhere, and that this report's goals were to examine maternal glycemia against additional/newborn anthropometric outcomes (sum of skin folds, individual skin folds, percent body fat) plus cord C-peptide. The Results report strong, graded, continuous associations for these outcomes (e.g., ORs 1.33–1.47 for percent body fat >90th percentile and 1.28–1.56 for individual skin folds), and the Discussion explicitly says 'This pattern is similar to that reported for maternal glucose and birth weight >90th percentile.' That covers the claim's substance — similar associations for the secondary/additional outcomes — even though the paper does not use the label 'secondary outcomes'. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
What the sources say
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
In the Results (Table 5), higher cord C-peptide, the paper’s measure of fetal insulin, is strongly associated with birth weight above the 90th percentile and adiposity measures. The Discussion states that the relationships persisted after adjustment for potential confounders. The paper does not claim that every possible confounder was excluded. (LLM, conf=0.92)
- Not checked yetcites [37] Metzger BE Silverman BL Freinkel N Dooley SL Ogata ES Green OC: Amniotic fluid insulin concentration as a predictor of obesity. Arch Dis Child 1990; 65: 1050– 1052 2241225 PMC1590256 source
- Not checked yetcites [38] Weiss PA Haeusler M Tamussino K Haas J: Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000; 107: 1480– 1485 11192103 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although not directly comparable, it was concluded that results of the two randomized controlled trials (47,48) and HAPO (25,26) are highly complementary.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM > Other considerations
What the sources say
- Supportedcites [47] Crowther CA Hiller JE Moss JR McPhee AJ Jeffries WS Robinson JS: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477– 2486 15951574 source
The paper identifies itself as a randomized clinical trial and reports its treatment results (secondary outcomes; page unavailable). In the citing sentence, this citation identifies one of the two trials whose results are being discussed; it does not attribute the cross-study judgment of complementarity to this trial paper. (LLM, conf=0.88)
- Not checked yetcites [48] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B Wapner RJ Varner MW Rouse DJ Thorp JM Jr Sciscione A Catalano P Harper M Saade G Lain KY Sorokin Y Peaceman AM Tolosa JE Anderson GB: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009: 361; 1339– 1348. PMC2804874 19797280
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Could not verifycites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 sourceExperimental — accuracy not yet measured
The Abstract reports HAPO findings on maternal glucose and pregnancy outcomes, but does not compare them with randomized trials. Searches for randomized trials and for the claimed complementarity found no passage in our copy making that comparison. No page numbers were available. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Importantly, there were continuous graded relationships between higher maternal glucose and increasing frequency of the primary outcomes, independent of other risk factors (25).”
- Also stated in: § Future considerations · boosted
“The HAPO study was a basic epidemiological investigation that for the first time conclusively identified strong continuous associations of maternal glucose levels below those diagnostic of diabetes with several perinatal outcomes.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Future considerations · boosted
None of the sources cited for this claim have been checked yet.
In the paper
“HAPO data show strong linear associations of risks for >90th percentiles of birth weight, cord C-peptide, and percent body fat with each of three measures of maternal glucose (FPG, 1-h, and 2-h post–75-g load).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 62 claims and to verify the 63 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GDM was identified when fasting blood glucose (FBG) ≥ 5.1 mmol/L during the first trimester or any plasma glucose after a 75 g OGTT performed as: FBG ≥ 5.1 mmol/L, 1 h after glucose load ≥ 10.0 mmol/L or 2 h after glucose load ≥ 8.5 mmol/L using the criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) [28].”
From Associations of maternal pre-pregnancy BMI and gestational weight gain with the risks of adverse pregnancy outcomes in Chinese women with gestational diabetes mellitus (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“to adopt diagnostic glucose thresholds corresponding to a HAPO OR of 1.75 (fasting plasma glucose [FPG] 5.1–6.9 mmol/L, one‐hour plasma glucose [1hPG] ≥ 10.0 mmol/L, and/or two‐hour plasma glucose [2hPG] 8.5–11.0 mmol/L). 14”
From Australasian Diabetes in Pregnancy Society ( ADIPS ) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The IADPSG diagnostic thresholds are the first criteria based on risks of adverse perinatal outcomes, rather than risk of subsequent development of maternal diabetes1 or by applying thresholds that define impaired glucose tolerance outside of pregnancy.5,6”
From Gestational Diabetes Mellitus (2019) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“following the diagnostic criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) (18)”
From Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre (2025) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Based on the HAPO Study and other studies, new criteria for the diagnosis of gestational diabetes were proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) 2 and adopted by the World Health Organization and others.3,4”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [2]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303 · cited 2×
“Long-term risks associated with fetal macrosomia in infants of women with GDM (independent of confounders) include childhood overweight (43,44) and metabolic factors that may increase risk of cardiovascular disease (CVD) (45).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
(1964) · PubMed · Cited by 1,230
Research works printed but not linked: 2
- Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Health Canada 1994; 15– 23
- National Collaborating Centre for Women's and Children's Health. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London, U.K., RCOG Press, 2008 21370515
Cited by
Items 201–300 of 1,132
Pregnancy Exercise and Nutrition With Smartphone Application Support: A Randomized Controlled Trial
Kennelly, M. A., Ainscough, K., Lindsay, K. L., O'Sullivan, E., Gibney, E. R., McCarthy, M., Segurado, R., DeVito, G., Maguire, O., Smith, T., et al. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002582 · Cited by 126
Chen, Y., Li, G., Ruan, Y., Zou, L., Wang, X., & Zhang, W. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-242 · Cited by 146
Lacroix, M., Battista, M.-C., Doyon, M., Ménard, J., Ardilouze, J.-L., Perron, P., & Hivert, M.-F. (2013) · Diabetes Care · doi:10.2337/dc12-1731 · Cited by 121
“Diagnosis of GDM was based on a standard 75-g OGTT and the most recent cutoffs recommended by IADPSG (19); none of the previous reports about adiponectin and GDM mentioned above were using the newest criteria.”
MethodInfluentialBogdanet, D., O’Shea, P., Lyons, C., Shafat, A., & Dunne, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113451 · Cited by 117
“75 g/kg body weight with a maximum of 75 g [72,81].”
BackgroundDonovan, L., Hartling, L., Muise, M., Guthrie, A., Vandermeer, B., & Dryden, D. M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00657 · Cited by 125
“Some stakeholders have recommended a 1-step diagnostic test for GDM because it results in a more rapid diagnosis of affected women (12); however, this approach has not been shown to be cost-effective (13).”
Egan, A. M., Dennedy, M. C., Al-Ramli, W., Heerey, A., Avalos, G., & Dunne, F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2684 · Cited by 125
“GDM was diagnosed using IADPSG criteria, after a 75-g oral glucose tolerance test at 24–28 weeks’ gestation (11, 12).”
MethodRetnakaran, R., Ye, C., Hanley, A. J. G., Connelly, P. W., Sermer, M., Zinman, B., & Hamilton, J. K. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.111154 · Cited by 125
Li, J., Song, C., Li, C., Liu, P., Sun, Z., & Yang, X. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.054 · Cited by 124
Poon, L. C., McIntyre, H. D., Hyett, J. A., da Fonseca, E. B., & Hod, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.002 · Cited by 116
Kunath, J., Günther, J., Rauh, K., Hoffmann, J., Stecher, L., Rosenfeld, E., Kick, L., Ulm, K., & Hauner, H. (2019) · BMC Medicine · doi:10.1186/s12916-018-1235-z · Cited by 108
Lamain-de Ruiter, M., Kwee, A., Naaktgeboren, C. A., de Groot, I., Evers, I. M., Groenendaal, F., Hering, Y. R., Huisjes, A. J. M., Kirpestein, C., Monincx, W. M., et al. (2016) · BMJ · doi:10.1136/bmj.i4338 · Cited by 123
Sex-Specific Associations of Gestational Glucose Tolerance With Childhood Body Composition
Regnault, N., Gillman, M. W., Rifas-Shiman, S. L., Eggleston, E., & Oken, E. (2013) · Diabetes Care · doi:10.2337/dc13-0333 · Cited by 120
Brown, F. M., & Wyckoff, J. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0922-z · Cited by 122
Mayo, K., Melamed, N., Vandenberghe, H., & Berger, H. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.08.027 · Cited by 122
Greenhalgh, T., Clinch, M., Afsar, N., Choudhury, Y., Sudra, R., Campbell-Richards, D., Claydon, A., Hitman, G. A., Hanson, P., & Finer, S. (2015) · BMC Medicine · doi:10.1186/s12916-015-0360-1 · Cited by 115
Lawlor, D. A., Richmond, R., Warrington, N., McMahon, G., Smith, G. D., Bowden, J., & Evans, D. M. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.10567.1 · Cited by 129
Falcone, V., Linder, T., Feichtinger, M., Kiss, H., Eppel, W., Husslein, P. W., Prager, G., & Göbl, C. S. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2124-3 · Cited by 141
Screening and diagnosing gestational diabetes mellitus.
Hartling, L., Dryden, D. M., Guthrie, A., Muise, M., Vandermeer, B., Aktary, W. M., Pasichnyk, D., Seida, J. C., & Donovan, L. (2012) · PubMed Central · Cited by 178
Metabolomics Reveals Broad-Scale Metabolic Perturbations in Hyperglycemic Mothers During Pregnancy
Scholtens, D. M., Muehlbauer, M. J., Daya, N. R., Stevens, R. D., Dyer, A. R., Lowe, L. P., Metzger, B. E., Newgard, C. B., Bain, J. R., Lowe, W. L., et al. (2014) · Diabetes Care · doi:10.2337/dc13-0989 · Cited by 117
“The high-FPG group included pregnant mothers who meet recently adopted IADPSG criteria for GDM, suggesting impaired b-cell function together with insulin resistance (7).”
BackgroundMethodWei, Y., Xu, Q., Yang, H., Yang, Y., Wang, L., Chen, H., Anderson, C., Liu, X., Song, G., Li, Q., et al. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002926 · Cited by 116
Santamaria, A., Di Benedetto, A., Petrella, E., Pintaudi, B., Corrado, F., D’Anna, R., Neri, I., & Facchinetti, F. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2015.1121478 · Cited by 114
“From the beginning of 2010, after the publication of the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study results [2], we follow the recommendations of the International Association of Diabetes in Pregnancy Study Group (IADPSG) [3] later modified in 2011 by American Diabetes Association (ADA) [4].”
InfluentialFarrar, D., Simmonds, M., Griffin, S., Duarte, A., Lawlor, D. A., Sculpher, M., Fairley, L., Golder, S., Tuffnell, D., Bland, M., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20860 · Cited by 117
Ye, Y., Xiong, Y., Zhou, Q., Wu, J., Li, X., & Xiao, X. (2020) · Journal of Diabetes Research · doi:10.1155/2020/4168340 · Cited by 132
Gestational diabetes mellitus is associated with the neonatal gut microbiota and metabolome
Chen, T., Qin, Y., Chen, M., Zhang, Y., Wang, X., Dong, T., Chen, G., Sun, X. L., Lu, T., White, R. A., III, et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01991-w · Cited by 143
“Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with an onset or first recognition during pregnancy, which is one of the most common types of pregnancy complications [1].”
BackgroundDiagnosis of gestational diabetes mellitus: falling through the net
Meek, C. L., Lewis, H. B., Patient, C., Murphy, H. R., & Simmons, D. (2015) · Diabetologia · doi:10.1007/s00125-015-3647-z · Cited by 114
“The IADPSG guidelines [11] now recommend screening pregnant women who are not known to have diabetes at 24–28weeks’ gestation using the OGTT and not the GCT.”
BackgroundMethodAre perfluorooctane sulfonate alternatives safer? New insights from a birth cohort study
Chu, C., Zhou, Y., Li, Q.-Q., Bloom, M. S., Lin, S., Yu, Y.-J., Chen, D., Yu, H.-Y., Hu, L.-W., Yang, B.-Y., et al. (2020) · Environment International · doi:10.1016/j.envint.2019.105365 · Cited by 117
Maternal diabetes mellitus and risk of neonatal respiratory distress syndrome: a meta-analysis
Li, Y., Wang, W., & Zhang, D. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01327-4 · Cited by 122
de Mendonça, E. L. S. S., Fragoso, M. B. T., de Oliveira, J. M., Xavier, J. A., Goulart, M. O. F., & de Oliveira, A. C. M. (2022) · Antioxidants · doi:10.3390/antiox11010129 · Cited by 126
Xu, T., Dainelli, L., Yu, K., Ma, L., Silva Zolezzi, I., Detzel, P., & Fang, H. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018893 · Cited by 116
“5%, based on the International Association of the Diabetes and Pregnancy Study Groups criteria.(5) In 2015, China’s population was approximately 1.”
BackgroundMethodInterventions for Preventing Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
Oostdam, N., van Poppel, M. N. M., Wouters, M. G. A. J., & van Mechelen, W. (2011) · Journal of Women's Health · doi:10.1089/jwh.2010.2703 · Cited by 114
Yuan, L., Qin, Y., Wang, L., Zeng, Y., Chang, H., Wang, J., Wang, B., Wan, J., Chen, S., Zhang, Q., et al. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.02.011 · Cited by 116
“The expected GDM incidence has been 16%e18% of pregnancies worldwide [1].”
BackgroundWestermeier, F., Salomón, C., González, M., Puebla, C., Guzmán‐Gutiérrez, E., Cifuentes, F., Leiva, A., Casanello, P. C., & Sobrevía, L. (2011) · Diabetes · doi:10.2337/db11-0155 · Cited by 116
Nankervis, A. J., McIntyre, D. H., Moses, R. G., Gp, R., Callaway, L. K., Porter, C., Jeffries, W. S., & Boorman, C. (2014) · Cited by 195
Gestational diabetes mellitus: does an effective prevention strategy exist?
Agha-Jaffar, R., Oliver, N. S., Johnston, D. G., & Robinson, S. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.88 · Cited by 132
Law, K. P., & Zhang, H. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.02.008 · Cited by 140
Circulating early- and mid-pregnancy microRNAs and risk of gestational diabetes
Wander, P. L., Boyko, E. J., Hevner, K., Parikh, V. J., Tadesse, M. G., Sorensen, T. K., Williams, M. A., & Enquobahrie, D. A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.024 · Cited by 111
Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis
Mission, J. F., Ohno, M. S., Cheng, Y. W., & Caughey, A. B. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.06.048 · Cited by 111
“Their analyses assumed that the benefits of GDM treatment would translate to the additional patients who would newly qualify for a GDM diagnosis under the new IADPSG criteria.31 To calculate the effects of treatment on cesarean section and other outcomes, this group used the results from a recent metaanalysis on perin…”
MethodInfluentialShort‐ and long‐term outcomes of gestational diabetes and its treatment on fetal development
Murray, S. R., & Reynolds, R. M. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5768 · Cited by 104
Sénat, M.-V., Affres, H., Letourneau, A., Coustols-Valat, M., Cazaubiel, M., Legardeur, H., Jacquier, J. F., Bourcigaux, N., Simon, E., Rod, A., et al. (2018) · JAMA · doi:10.1001/jama.2018.4072 · Cited by 114
Ming, W.-K., Ding, W., Zhang, C. J. P., Zhong, L., Long, Y., Li, Z., Sun, C., Wu, Y., Chen, H., Chen, H., et al. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2068-7 · Cited by 114
“In 2013, the World Health Organization (WHO) adopted the IADPSG evidence-based criteria as their standard for GDM diagnosis [2, 3]; these criteria use lower thresholds for several indices (i.”
MethodLawlor, D. A. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys209 · Cited by 114
Stern, C., Schwarz, S., Moser, G., Cvitic, S., Jantscher-Krenn, E., Gauster, M., & Hiden, U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312722 · Cited by 114
Early pregnancy immune biomarkers in peripheral blood may predict preeclampsia
Garcia, M. D. S., Mobley, Y. R., Henson, J. T., Davies, M., Skariah, A. M., Dambaeva, S. V., Gilman‐Sachs, A., Beaman, K. D., Lampley, E. C., & Kwak-Kim, J. Y.-H. (2017) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2017.10.048 · Cited by 123
Nogues, P., Santos, E. D., Jammes, H., Berveiller, P., Arnould, L., Vialard, F., & Dieudonné, M. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0612-6 · Cited by 122
Homko, C. J., Deeb, L. C., Rohrbacher, K., Mulla, W., Mastrogiannis, D., Gaughan, J., Santamore, W. P., & Bove, A. A. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0010 · Cited by 112
Gestational diabetes among Saudi women: prevalence, risk factors and pregnancy outcomes
Alfadhli, E. M., Osman, E. N., Basri, T. H., Mansuri, N. S., Youssef, M. H., Assaaedi, S. A., & Aljohani, B. A. (2015) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2015.222 · Cited by 104
Non-Coding RNA: Role in Gestational Diabetes Pathophysiology and Complications
Filardi, T., Catanzaro, G., Mardente, S., Zicari, A., Santangelo, C., Lenzi, A., Morano, S., & Ferretti, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114020 · Cited by 120
Goyal, A., Gupta, Y., Singla, R., Kalra, S., & Tandon, N. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00865-3 · Cited by 105
Is There a Role for HbA1c in Pregnancy?
Hughes, R. C. E., Rowan, J., & Florkowski, C. M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0698-y · Cited by 127
“3 Canterbury Health Laboratories, PO Box 151, Christchurch 8140, New Zealand Curr Diab Rep (2016) 16: 5”
BackgroundMethodWaters, T. P., Dyer, A. R., Scholtens, D. M., Dooley, S. L., Herer, E., Lowe, L. P., Oats, J. J. N., Persson, B., Sacks, D. A., Metzger, B. E., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1194 · Cited by 111
Utility of HbA1c for diagnosis of gestational diabetes mellitus
Rajput, R., YogeshYadav, Rajput, M., & Nanda, S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.018 · Cited by 127
“The time required and samples collected can be higher depending upon the criteria followed [2–4].”
BackgroundInfluentialPre-existing diabetes mellitus and adverse pregnancy outcomes
Wahabi, H. A., Esmaeil, S. A., Fayed, A., Al-Shaikh, G., & Alzeidan, R. A. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-496 · Cited by 108
“Because of the documented high prevalence of T2DM in the Saudi population we recommend that all pregnant women be screened early in pregnancy (during the first trimester) using fasting blood glucose to identify women with PDM [32].”
MethodLi, G., Kong, L., Li, Z., Zhang, L., Fan, L., Zou, L., Chen, Y., Ruan, Y., Wang, X., & Zhang, W. (2014) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12133 · Cited by 109
Mitanchez, D., Burguet, A., & Siméoni, U. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.10.076 · Cited by 134
Yumei, W., Huixia, Y., Weiwei, Z., Hongyun, Y., Haixia, L., Jie, Y., & Cuilin, Z. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20140898 · Cited by 109
Diabetes and pregnancy: perspectives from Asia
Tutino, G. E., Tam, W. H., Yang, X., Chan, J. C. N., Lao, T. T. H., & Ma, R. C. W. (2014) · Diabetic Medicine · doi:10.1111/dme.12396 · Cited by 107
Molecular Biomarkers for Gestational Diabetes Mellitus
Dias, S. C., Pheiffer, C., Abrahams, Y., Rheeder, P., & Adam, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102926 · Cited by 120
Cytokine Levels in Gestational Diabetes Mellitus: a Systematic Review of the Literature
Gomes, C. P., Torloni, M. R., Gueuvoghlanian‐Silva, B. Y., Alexandre, S. M., Mattar, R., & Daher, S. (2013) · American Journal of Reproductive Immunology · doi:10.1111/aji.12088 · Cited by 105
Hiramatsu, Y., Shimizu, I., Omori, Y., & Nakabayashi, M. (2012) · Endocrine Journal · doi:10.1507/endocrj.k10e-410 · Cited by 106
RETIRED: Diabetes in Pregnancy
Berger, H., Gagnon, R., & Sermer, M. (2016) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.04.002 · Cited by 108
Genetics of Gestational Diabetes Mellitus and Maternal Metabolism
Lowe, W. L., Scholtens, D. M., Sandler, V., & Hayes, M. G. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0709-z · Cited by 108
Draffin, C. R., Alderdice, F. A., McCance, D. R., Maresh, M., Harper, M. (. P., McSorley, O., & Holmes, V. A. (2016) · Midwifery · doi:10.1016/j.midw.2016.06.019 · Cited by 108
Miao, M., Dai, M., Zhang, Y., Sun, F., Guo, X., & Sun, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-00441-z · Cited by 107
Gestational Diabetes Mellitus and Cardiovascular Risk after Pregnancy
Harreiter, J., Dovjak, G., & Kautzky-Willer, A. (2014) · Women's Health · doi:10.2217/whe.13.69 · Cited by 106
Early diagnosis of gestational diabetes mellitus using circulating microRNAs
Yoffe, L., Polsky, A. L., Gilam, A., Raff, C., Mecacci, F., Ognibene, A., Crispi, F., Gratacós, E., Kanety, H., Mazaki‐Tovi, S., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0206 · Cited by 114
Sheiner, E. (2020) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2020.546256 · Cited by 122
Riskin‐Mashiah, S., Damti, A., Younes, G., & Auslender, R. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.05.036 · Cited by 117
Guideline No. 393-Diabetes in Pregnancy
Berger, H., Gagnon, R., & Sermer, M. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.03.008 · Cited by 106
Jelsma, J. G., van Poppel, M. N., Galjaard, S., Desoye, G., Corcoy, R., Devlieger, R., van Assche, A., Timmerman, D., Jans, G., Harreiter, J., et al. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-142 · Cited by 104
“at baseline measurement [18]; have pre-existing diabetes; are not able to walk at least 100 meter safely; require complex diets; have chronic medical conditions (e.”
Diabetes gestacional: um algoritmo de tratamento multidisciplinar
Weinert, L. S., Silveiro, S. P., Oppermann, M. L. D. R., Salazar, C. C., Simionato, B. M., Siebeneichler, A., & Reichelt, A. J. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000700002 · Cited by 153
Feldman, R. K., Tieu, R. S., & Yasumura, L. (2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001132 · Cited by 105
Lapolla, A., Dalfrà, M. G., Ragazzi, E., De Cata, A. P., & Fedele, D. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03351.x · Cited by 105
Exercise for pregnant women with gestational diabetes for improving maternal and fetal outcomes
Brown, J., Ceysens, G., & Boulvain, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012202.pub2 · Cited by 98
Kim, J., Piao, Y., Pak, Y. K., Chung, D.-H., Han, Y. M., Hong, J. S., Jun, E. J., Shim, J., Choi, J., & Kim, C. J. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0349 · Cited by 109
“The diagnosis of GDM was based on the International Association of Diabetes and Pregnancy Study Groups Consensus and Panel recommendations [19].”
Freathy, R. M., Hayes, M. G., Urbanek, M., Lowe, L. P., Lee, H., Ackerman, C., Frayling, T. M., Cox, N. J., Dunger, D. B., Dyer, A. R., et al. (2010) · Diabetes · doi:10.2337/db10-0177 · Cited by 106
Diabetes in pregnancy outcomes: A systematic review and proposed codification of definitions
The International Association of Diabetes in Pregnancy Study Group (IADPSG) Working Group on Outcome Definitions, Feig, D. S., Corcoy, R., Jensen, D. M., Kautzky‐Willer, A., Nolan, C. J., Oats, J. J. N., Sacks, D. A., Caimari, F., & McIntyre, H. D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2640 · Cited by 100
Gestational diabetes and the risk of late stillbirth: a case–control study from England, UK
Stacey, T., Tennant, P., McCowan, L., Mitchell, E., Budd, J., Li, M., Thompson, J., Martin, B., Roberts, D., & Heazell, A. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15659 · Cited by 95
RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy
Paolino, M., Koglgruber, R., Cronin, S. J. F., Uribesalgo, I., Rauscher, E., Harreiter, J., Schuster, M. K., Bancher‐Todesca, D., Pranjic, B., Novatchkova, M., et al. (2020) · Nature · doi:10.1038/s41586-020-03071-0 · Cited by 112
Placental structural abnormalities in gestational diabetes and when they develop: A scoping review
Ehlers, E., Talton, O. O., Schust, D. J., & Schulz, L. C. (2021) · Placenta · doi:10.1016/j.placenta.2021.04.005 · Cited by 113
Pillay, J., Donovan, L., Guitard, S., Zakher, B., Gates, M., Gates, A., Vandermeer, B., Bougatsos, C., Chou, R., & Hartling, L. (2021) · JAMA · doi:10.1001/jama.2021.10404 · Cited by 99
Harreiter, J., Simmons, D., Desoye, G., Corcoy, R., Adelantado, J. M., Devlieger, R., van Assche, A., Galjaard, S., Damm, P., Mathiesen, E. R., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0200 · Cited by 103
Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring
Vrachnis, N., Antonakopoulos, N., Iliodromiti, Z., Dafopoulos, K., Siristatidis, C., Pappa, K. I., Deligeoroglou, E., & Vitoratos, N. (2012) · Experimental Diabetes Research · doi:10.1155/2012/538474 · Cited by 103
Arora, G. P., Thaman, R. G., Prasad, R. B., Almgren, P., Brøns, C., Groop, L. C., & Vaag, A. A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0428 · Cited by 103
Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes
Brown, J., Martis, R., Hughes, B., Rowan, J., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011967.pub2 · Cited by 95
Guillemette, L., Allard, C., Lacroix, M., Patenaude, J., Battista, M.-C., Doyon, M., Moreau, J., Ménard, J., Bouchard, L., Ardilouze, J.-L., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010031 · Cited by 100
Wang, Y., Huang, Y., Wu, P., Ye, Y., Sun, F., Yang, X., Lu, Q., Yuan, J., Liu, Y., Zeng, H., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab242 · Cited by 109
Mohan, V., Mahalakshmi, M. M., Bhavadharini, B., Maheswari, K., Kalaiyarasi, G., Anjana, R. M., Uma, R., Usha, S., Deepa, M., Unnikrishnan, R., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0660-5 · Cited by 101
Probiotics for preventing gestational diabetes
Barrett, H. L., Dekker Nitert, M., Conwell, L. S., & Callaway, L. K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009951.pub2 · Cited by 101
Antoun, E., Kitaba, N. T., Titcombe, P., Dalrymple, K. V., Garratt, E. S., Barton, S. J., Murray, R. J. S., Seed, P. T., Holbrook, J. D., Kobor, M. S., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003229 · Cited by 114
Fu, J. M., & Retnakaran, R. R. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101294 · Cited by 111
Ye, D., Huang, J., Wu, J., Xie, K., Gao, X., Yan, K., Zhang, P., Tao, Y., Li, Y., Zang, S., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2154552 · Cited by 105
“GDM was diagnosed when OGTT value fulfilled at least one of the following criteria: FPG ≥ 92 mg/dL, 1-h plasma glucose ≥180 mg/dL or 2-h plasma glucose ≥153 mg/dL.(45) Pregnant women with NGT were defined as those with normal glucose levels on OGTT screening during the second trimester.”
MethodMaternal age, ethnicity and gestational diabetes mellitus
Carolan, M. C., Davey, M., Biró, M. A., & Kealy, M. (2011) · Midwifery · doi:10.1016/j.midw.2011.08.014 · Cited by 116
Gaps in Diabetes Screening During Pregnancy and Postpartum
Blatt, A. J., Nakamoto, J. M., & Kaufman, H. W. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181fe424b · Cited by 99
Natamba, B. K., Namara, A. A., & Nyirenda, M. J. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2593-z · Cited by 100
Chen, X., Zhang, Y., Chen, H., Jiang, Y., Wang, Y., Wang, D., Li, M., Dou, Y., Sun, X., Huang, G., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1607 · Cited by 100
Progression of Cardio-Metabolic Risk Factors in Subjects Born Small and Large for Gestational Age
Chiavaroli, V., Marcovecchio, M. L., de Giorgis, T., Diesse, L., Chiarelli, F., & Mohn, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104278 · Cited by 115
Crawford, T. J., Crowther, C. A., Alsweiler, J., & Brown, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011507.pub2 · Cited by 96
Avalos, G. E., Owens, L. A., Dunne, F., & Collaborators, F. T. A. D. (2013) · Diabetes Care · doi:10.2337/dc12-2669 · Cited by 97
Li, M., Zeng, X., Qian, Z. M., Vaughn, M. G., Sauvé, S., Paul, G. E., Lin, S., Lü, L., Hu, L., Yang, B., et al. (2017) · Environment International · doi:10.1016/j.envint.2017.03.006 · Cited by 106
WEI, Q., SUN, Z., YANG, Y., YU, H., DING, H., & WANG, S. (2016) · Scientific Reports · doi:10.1038/srep19920 · Cited by 99
Metadata
- Authors
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Corresponding author
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-03-01
- Volume
- 33
- Issue
- 3
- Pages
- 676-682
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2827530
- OpenAlex
- W2616235706
- Cited by
- 5,390
- References
- 56
- Citations by year
- 2026: 314 · 2025: 377 · 2024: 446 · 2023: 423 · 2022: 494 · 2021: 507 · 2020: 425 · 2019: 350 · 2018: 367 · 2017: 297 · 2016: 274 · 2015: 296 · 2014: 235 · 2013: 203 · 2012: 167
- FWCI
- 250.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- American Diabetes Association
- Kaiser Permanente
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34243, R01-HD-34242, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, hyperglycemia in pregnancy, IADPSG criteria, perinatal outcomes, maternal glycemia, diagnostic thresholds
- MeSH terms
- Female, Health Planning Guidelines, Humans, Hyperglycemia, International Cooperation, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Societies, Medical, Diabetes, Gestational, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.